162 related articles for article (PubMed ID: 18071295)
1. Bretylium abolishes neurotransmitter release without necessarily abolishing the nerve terminal action potential in sympathetic terminals.
Brain KL; Cunnane TC
Br J Pharmacol; 2008 Feb; 153(4):831-9. PubMed ID: 18071295
[TBL] [Abstract][Full Text] [Related]
2. Intermittent ATP release from nerve terminals elicits focal smooth muscle Ca2+ transients in mouse vas deferens.
Brain KL; Jackson VM; Trout SJ; Cunnane TC
J Physiol; 2002 Jun; 541(Pt 3):849-62. PubMed ID: 12068045
[TBL] [Abstract][Full Text] [Related]
3. Electrical and optical study of nerve impulse-evoked ATP-induced, P2X-receptor-mediated sympathetic neurotransmission at single smooth muscle cells in mouse isolated VAS deferens.
Young JS; Brain KL; Cunnane TC
Neuroscience; 2007 Aug; 148(1):82-91. PubMed ID: 17629625
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in nicotinic acetylcholine receptor-induced neurotransmitter release from sympathetic nerve terminals in the mouse vas deferens.
Williams DJ; Sidaway P; Cunnane TC; Brain KL
PLoS One; 2011; 6(12):e29209. PubMed ID: 22216213
[TBL] [Abstract][Full Text] [Related]
5. Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate.
Parker LK; Shanks JA; Kennard JA; Brain KL
Br J Pharmacol; 2010 Feb; 159(4):797-807. PubMed ID: 20136837
[TBL] [Abstract][Full Text] [Related]
6. Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens.
Jackson VM; Cunnane TC
Br J Pharmacol; 2002 Apr; 135(8):1845-50. PubMed ID: 11959786
[TBL] [Abstract][Full Text] [Related]
7. The sources and sequestration of Ca(2+) contributing to neuroeffector Ca(2+) transients in the mouse vas deferens.
Brain KL; Cuprian AM; Williams DJ; Cunnane TC
J Physiol; 2003 Dec; 553(Pt 2):627-35. PubMed ID: 14500773
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of catecholamine release from the sympathetic nerve endings, particularly in its relation tovacetylcholine an experiment on the isolated vas deferens of rats].
Ueba R
Nihon Yakurigaku Zasshi; 1976; 72(1):127-137. PubMed ID: 986346
[TBL] [Abstract][Full Text] [Related]
9. Neuroeffector Ca2+ transients for the direct measurement of purine release and indirect measurement of cotransmitters in rodents.
Brain KL
Exp Physiol; 2009 Jan; 94(1):25-30. PubMed ID: 18805863
[TBL] [Abstract][Full Text] [Related]
10. Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium stores.
Brain KL; Trout SJ; Jackson VM; Dass N; Cunnane TC
Neuroscience; 2001; 106(2):395-403. PubMed ID: 11566509
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerve fibres.
Brock JA; Cunnane TC
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):504-9. PubMed ID: 3244392
[TBL] [Abstract][Full Text] [Related]
12. Selective release of ATP from sympathetic nerves of rat vas deferens by the toxin TsTX-I from Brazilian scorpion Tityus serrulatus.
Conceição IM; Jurkiewicz A; Fonseca DR; Opperman AR; Freitas TA; Lebrun I; Garcez-do-Carmo L
Br J Pharmacol; 2005 Feb; 144(4):519-27. PubMed ID: 15678093
[TBL] [Abstract][Full Text] [Related]
13. Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, noradrenaline and neuropeptide Y.
Wier WG; Zang WJ; Lamont C; Raina H
Exp Physiol; 2009 Jan; 94(1):31-7. PubMed ID: 18931047
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide adenine dinucleotide is released from sympathetic nerve terminals via a botulinum neurotoxin A-mediated mechanism in canine mesenteric artery.
Smyth LM; Breen LT; Mutafova-Yambolieva VN
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1818-25. PubMed ID: 16339824
[TBL] [Abstract][Full Text] [Related]
15. High spatial resolution studies of muscarinic neuroeffector junctions in mouse isolated vas deferens.
Cuprian-Beltechi AM; Solanki P; Teramoto N; Cunnane TC
Neuroscience; 2009 Sep; 162(4):1366-76. PubMed ID: 19486927
[TBL] [Abstract][Full Text] [Related]
16. Vas deferens--a model used to establish sympathetic cotransmission.
Burnstock G; Verkhratsky A
Trends Pharmacol Sci; 2010 Mar; 31(3):131-9. PubMed ID: 20074819
[TBL] [Abstract][Full Text] [Related]
17. Evidence that action potential-induced Ca2+ influx is necessary but not sufficient to release transmitter from sympathetic nerve terminals.
Msghina M; Stjärne E; Astrand P; Stjärne L
Acta Physiol Scand; 1990 Feb; 138(2):239-40. PubMed ID: 1969221
[No Abstract] [Full Text] [Related]
18. Do alpha 2-agonists inhibit sympathetic transmitter secretion in part by depressing a Ca2+ component of the nerve impulse 'upstream' of varicosities?
Stjärne C; Stjärne E; Msghina M
Acta Physiol Scand; 1988 Aug; 133(4):591-2. PubMed ID: 2906514
[No Abstract] [Full Text] [Related]
19. Role of N-, P- and Q-type voltage-gated calcium channels in transmitter release from sympathetic neurones in the mouse isolated vas deferens.
Waterman SA
Br J Pharmacol; 1997 Feb; 120(3):393-8. PubMed ID: 9031741
[TBL] [Abstract][Full Text] [Related]
20. Ryanodine-sensitive calcium stores involved in neurotransmitter release from sympathetic nerve terminals of the guinea-pig.
Smith AB; Cunnane TC
J Physiol; 1996 Dec; 497 ( Pt 3)(Pt 3):657-64. PubMed ID: 9003551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
